• Nicotine Vape Prescriptions Online

HolisticChem provides professional support for adult Australians seeking help to reduce or stop smoking, or to manage nicotine dependence using regulated and lawful treatment options. We understand that deciding to quit is not easy — but once that decision is made, access to care should be simple, respectful, and timely.

Our service is designed to remove common barriers such as long wait times, crowded clinics, and unnecessary judgement. We focus on convenience, privacy, and clear clinical guidance, so you can move forward with confidence and without delay.

Smoking-related health risks are widely recognised, and many individuals have already tried multiple approaches such as nicotine patches, gums, medications, or quitting abruptly — often without long-term success. That’s why we support clinically guided alternatives that may be appropriate for people at different stages of their cessation journey.

Choosing to quit is a meaningful step toward better health. When you’re ready to begin, professional support can make all the difference. Start your journey today and take control of your wellbeing.

Australian Registered Healthcare 
Professionals Including Authorised Prescribers

Nicotine Dependency and Smoking Cessation Treatments

Information provided in a factual, transparent, and balanced manner, with a focus on informed outcomes

Fact 1

Smoking and Vaping Trends in Australia

More than 10% of Australian adults continue to smoke despite well-established health risks. Research indicates that a significant proportion of smokers have previously attempted to quit or change their behaviour without long-term success. In parallel, an estimated 1.7 million adults report using vaping products. A large portion of these products are sourced from unregulated markets, where there is limited oversight of manufacturing standards or ingredients. A range of evidence-based treatment options exists to support smoking cessation and nicotine dependence management.

Read More
Fact 2

Available Cessation Pathways

Nicotine replacement therapies and certain prescription medications are considered first-line treatments and are approved by the Therapeutic Goods Administration (TGA). Since October 2021, nicotine vaping products have been classified as a second-line option for adults who have attempted approved therapies without success. Access is subject to medical oversight to reduce inappropriate use, particularly among non-smokers and young people. These products are regulated to minimum standards, unlike those obtained through illicit supply channels.

Read More
Fact 3

Understanding Changes to Vaping Regulations

In October 2021, regulation initially focused on nicotine-containing vaping products intended for therapeutic use. Challenges arose when some imported products were inaccurately labelled, complicating enforcement. Regulatory updates now seek to include both nicotine and non-nicotine vaping products under tighter controls. As a result, lawful access is limited to Australian pharmacies. Products sourced elsewhere may present unknown risks due to uncertain quality and composition.

Read More
Fact 4

The Role of Nicotine

Nicotine is addictive and not without risk, however it is not the primary contributor to smoking-related disease. The majority of harm from smoking arises from toxic chemicals produced when tobacco is burned. Nicotine itself is also used in established therapies such as patches and gums; the key difference lies in the method of delivery rather than the substance itself.

Read More
Fact 5

Reducing Harm Exposure

Unlike cigarettes, nicotine vaping products do not involve combustion and instead generate an aerosol. Evidence suggests that, when manufactured to regulated standards, exposure to harmful substances is substantially lower than continued smoking. These products are not suitable for non-smokers. For adults who smoke and have been unable to quit using approved therapies, medically supervised options may be considered as part of a broader cessation strategy.

Read More
Fact 6

Vaping Products Are Not All the Same

Vaping represents a broad category of products with varying quality and safety profiles. Certain health incidents have been linked to specific prohibited substances, including diacetyl and vitamin E acetate. These ingredients are not permitted in legally supplied Australian pharmacy products. Illicit products have been found to contain restricted substances and inaccurate labelling, increasing potential health risks.

Read More
Fact 7

Reviewing the Evidence Base

Independent reviews, including analyses by Cochrane, indicate that nicotine vaping products may be more effective than some traditional nicotine replacement therapies for smoking cessation. Additional findings suggest comparable effectiveness to certain prescription medications, with fewer serious adverse effects reported. Ongoing research continues to refine clinical guidance.

Read More
Fact 8

Nicotine Absorption Methods

The way nicotine is delivered can influence how cravings are managed. Cigarette smoke delivers nicotine rapidly via the lungs, whereas patches and gums absorb more slowly through the skin or oral tissues. Inhaled nicotine delivery more closely mimics the timing experienced by smokers, which may assist some individuals during cessation efforts.

Read More
Fact 9

Behavioural and Social Factors

Smoking involves behavioural patterns as well as nicotine dependence. Elements such as hand-to-mouth action and social routines can play a role in habit formation. Some cessation approaches aim to address these behavioural components alongside pharmacological support, recognising that quitting is both a physical and behavioural process.

Read More
Fact 10

Considering Long-Term Uncertainty

Nicotine vaping products have been available for approximately two decades, meaning long-term population data is still developing. Current evidence suggests substantially lower exposure to harmful substances compared with cigarette smoke when products meet regulatory standards. These products are not risk free and should only be considered by adults who have been unable to quit using approved first-line therapies or who are managing existing nicotine dependence under medical guidance.

Read More

How It Works

  • 01 Online Application

    Apply online for a 12-month prescription or upload an existing e-script.

  • 02 Get Notified

    Your submission is assessed by a registered medical practitioner to determine clinical eligibility.

  • 03 Shop Pharmacy

    Following approval, access to affiliated pharmacy services is provided for prescription fulfilment.

Available Products

Make it stand out.

Contact Us

Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!